$Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)$

Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)

Podrobná bibliografie
Hlavní autoři:	Dinardo, CD, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Zeidan, AM, Chen, C, Lord-Bessen, J, Yu, P, Shi, L, Guo, S, Bluemmert, I, Yu, X, Hasan, M, Martin Regueira, P, De Botton, S
Médium:	Journal article
Jazyk:	English
Vydáno:	American Society of Clinical Oncology 2022

Podobné jednotky

Health-related quality of life (HRQoL) during treatment with enasidenib (ENA) plus azacitidine (AZA) in patients with newly diagnosed mutant IDH2 (m IDH2) acute myeloid leukemia (AML) not eligible for intensive chemotherapy (IC)
Autor: DiNardo, CD, a další
Vydáno: (2021)

Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the randomized, phase 3 IDHentify Trial
Autor: DiNardo, CD, a další
Vydáno: (2021)

Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML
Autor: Risueño, A, a další
Vydáno: (2024)

AML-432 Overall survival (OS) by IDH2 mutant allele (R140 or R172) in patients with late-stage, mutant-IDH2 relapsed/refractory acute myeloid leukemia (AML) treated with enasidenib or conventional care regimens (CCR) in the randomized, open-label, Phase 3 IDHENTIFY Trial
Autor: DiNardo, CD, a další
Vydáno: (2022)

Overall survival by IDH2 mutant allele (R140 or R172) in patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia treated with enasidenib or conventional care regimens in the phase 3 IDHENTIFY trial
Autor: De Botton, S, a další
Vydáno: (2022)

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
Autor: de Botton, S, a další
Vydáno: (2022)

A phase 3 study of Enasidenib (ENA) versus conventional care regimens (CCR) in older patients with late-stage mutant-IDH2 (MIDH2) relapsed/refractory acute myeloid leukemia (R/R AML)
Autor: Papayannidis, C, a další
Vydáno: (2021)

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
Autor: DiNardo, CD, a další
Vydáno: (2021)

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Autor: Stein, EM, a další
Vydáno: (2017)

Self-reported health-related quality of life (HRQoL) and factors affecting HRQoL among individuals with health insurance in Iran
Autor: Ali Kazemi Karyani, a další
Vydáno: (2016-10-01)

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
Autor: Stein, EM, a další
Vydáno: (2018)

Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib
Autor: Vyas, P, a další
Vydáno: (2018)

The challenges of classical galactosemia: HRQoL in pediatric and adult patients
Autor: Merel E. Hermans, a další
Vydáno: (2023-06-01)

Higher perceived HRQoL in Moroccan children with asthma and their parents
Autor: Monique Theodora Maria Veenstra-van Schie, a další
Vydáno: (2015-05-01)

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Autor: Keith W. Pratz, a další
Vydáno: (2022-04-01)

Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
Autor: Quek, L, a další
Vydáno: (2017)

Molecular features associated with response to enasidenib plus azacitidine in newly diagnosed IDH2-mutated acute myeloid leukemia
Autor: Risueño, A, a další
Vydáno: (2023)

HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
Autor: Tri Wahyu Martanto, a další
Vydáno: (2023-10-01)

Socioeconomic inequalities in HRQoL in England: an age-sex stratified analysis
Autor: Paul Schneider, a další
Vydáno: (2022-08-01)

The association between diabetes mellitus and HRQoL of older people in Shanghai
Autor: Shiyin Tian, a další
Vydáno: (2021-11-01)

Health-Related Quality of Life (HRQoL) of Patients with Tuberculosis: A Review
Autor: Sandul Yasobant, a další
Vydáno: (2022-07-01)

The health gap and HRQoL inequalities in Greece before and during the economic crisis
Autor: John Yfantopoulos, a další
Vydáno: (2023-06-01)

Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
Autor: Ute Niehammer, a další
Vydáno: (2022-10-01)

Trait-Based Emotional Intelligence, Body Image Dissatisfaction, and HRQoL in Children
Autor: Olga Pollatos, a další
Vydáno: (2020-01-01)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes
Autor: Lesley Ann Saketkoo, a další
Vydáno: (2021-06-01)

Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer
Autor: Ijeoma N. C. Chibuzo, a další
Vydáno: (2021-01-01)

Factors affecting health-related quality of life (HRQoL) in Pakistani children with thalassemia
Autor: Narjis Batool, a další
Vydáno: (2022-03-01)

Differential associations of sex and age with changes in HRQoL during outpatient cardiac rehabilitation
Autor: Lorenza L. S. Lanini, a další
Vydáno: (2024-01-01)

Impact of smoking status on health-related quality of life (HRQoL) in cancer survivors
Autor: José Ignacio Nolazco, a další
Vydáno: (2024-01-01)

Knowledge about Fibromyalgia in Fibromyalgia Patients and Its Relation to HRQoL and Physical Activity
Autor: María Mendoza-Muñoz, a další
Vydáno: (2021-07-01)

Waist–Calf Circumference Ratio Is an Independent Risk Factor of HRQoL in Centenarians
Autor: Yang S, a další
Vydáno: (2020-02-01)

Understanding the role of discriminative instruments in HRQoL research: can Ferguson's Delta help?
Autor: Wyrwich Kathleen W
Vydáno: (2008-10-01)

Impact, distress and HRQoL among Malaysian men and women with a mobility impairment
Autor: Omar Zaliha, a další
Vydáno: (2006-12-01)

Measuring adolescents' HRQoL via self reports and parent proxy reports: an evaluation of the psychometric properties of both versions of the KINDL-R instrument
Autor: Ravens-Sieberer Ulrike, a další
Vydáno: (2009-08-01)

The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia
Autor: Bullinger Monika, a další
Vydáno: (2021-05-01)

Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma
Autor: Christopher W. Chalaka, MD, a další
Vydáno: (2023-06-01)

Predicting panel attrition in longitudinal HRQoL surveys during the COVID-19 pandemic in the US
Autor: Tianzhou Yu, a další
Vydáno: (2022-07-01)

Weight associated factors in relation to health-related quality of life (HRQoL) in Iranian adolescents
Autor: Sara Jalali-Farahani, a další
Vydáno: (2019-01-01)

Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review.
Autor: Valérie Leclair, a další
Vydáno: (2016-01-01)

Using self-determination theory to predict self-management and HRQoL in moderate-to-severe COPD
Autor: Liam Knox, a další
Vydáno: (2021-01-01)